Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Human immunodeficiency virus and resistance]

J Coórdoba1, M C Otero, B Laínez

  • 1Servicio de Microbiología, Hospital La Fe, Valencia.

Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|October 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

First-generation merozoites of caprine <i>Eimeria christenseni</i> are capable to invade and egress primary host endothelial cells <i>in vitro</i>.

Frontiers in veterinary science·2025
Same author

Outcomes of patients hospitalized in ward settings for COVID-19 pneumonia with or without early empirical antibiotics.

The Journal of antimicrobial chemotherapy·2024
Same author

Synergistic energy-efficient capture of VOCs and metal-free catalytic conversion using magneto-inductive Guefoams: Proof-of-concept in n-hexane-enriched nitrogen streams.

Journal of hazardous materials·2024
Same author

Immunization with thiol-binding proteins from Haemonchus contortus adult worms partially protects goats against infection during prepatency.

Experimental parasitology·2023
Same author

Population pharmacokinetics and pharmacodynamics of imipenem in neutropenic adult patients.

Infectious diseases now·2022
Same author

Treatment With a Three-Drug Regimen for Pulmonary Tuberculosis Based on Rapid Molecular Detection of Isoniazid Resistance: A Noninferiority Randomized Trial (FAST-TB).

Open forum infectious diseases·2022

The LiPA HIV-1 RT test can identify mutations in reverse transcriptase, aiding in the retrospective identification of nucleoside analog treatments. Direct sequencing remains the gold standard for comprehensive genetic analysis of HIV-1 resistance.

Area of Science:

  • Virology
  • Molecular Biology
  • Genetics

Context:

  • Prolonged treatment with reverse transcriptase inhibitors, particularly nucleoside analogs, can lead to the emergence of drug-resistant HIV-1 strains.
  • Mutations in the reverse transcriptase gene accumulate, causing amino acid changes that confer resistance to antiretroviral therapies.

Purpose:

  • This study evaluated the utility of the LiPA HIV-1 RT test for detecting mutations associated with antiretroviral treatment resistance.
  • To assess the test's ability to retrospectively identify specific nucleoside analog treatments based on detected mutations.

Summary:

  • The LiPA HIV-1 RT test was applied to 21 patient samples. No mutations were found in HIV-1 strains from untreated patients.
  • In treated patients, the test successfully identified nucleoside analogs used, with mutations conferring resistance to AZT and ddl being most prevalent, correlating with treatment history.

Related Experiment Videos

  • The test identified mutations linked to AZT resistance most frequently, followed by ddl resistance, reflecting common treatment regimens.

    • Impact:

    • The LiPA HIV-1 RT test offers a valuable tool for retrospectively identifying antiretroviral drug resistance patterns.
    • Limitations include the inability to detect all possible mutations; incorporating protease gene sequencing would enhance its clinical utility.
    • Direct sequencing remains the definitive method for complete genotypic resistance analysis in HIV-1 treatment management.